Press Releases

HI-TECH PHARMACAL LAUNCHES MAIL ORDER CATALOGUE FOR PEOPLE WITH DIABETES

Amityville, NY, May 11, 2001— Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that it had launched a mail order catalogue of nutritional products specially formulated for people with diabetes. Among the products in the catalogue named “Diabetic Health” are Multivitamin Formula, Eye Care Formula and Neuropathy Formula based on a number of well recognized nutritional supplements, such as Chromium, Vitamin E, Alpha-lipoic Acid, Vanadyl Sulfate, Bilberry Extract, and Coenzyme Q10. Also included in the catalogue are pharmaceutical products for people with diabetes marketed by the Health Care Products Division of Hi-Tech, including the Diabetic TussinTM line of cough & cold products.

Commenting on the launch of the mail order catalogue, David Seltzer, President and CEO of Hi-Tech said: “We are very excited about the catalogue which gives us a foothold in the growing nutritional supplement arena. Extensive market research has shown that people with diabetes use a variety of nutritional supplements. With the growing number of people affected by the disease, as well as general health and diet conscious consumer population, we see tremendous opportunities in participating in this fast growing marketplace.” Mr. Seltzer added: ”We remain committed to our mission of helping people with diabetes live healthier lives and are focused on the products that address their special needs, like sugar free cough & cold remedies, skin moisturizers and sugar substitutes. We also plan to launch an Internet catalogue of nutritional supplements through our website diabeticproducts.com, as well as initiate retail distribution of these products.”

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission, copies of which are available from the Company. “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. This release contains forward looking statements that are subject to risk and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission.